Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02122471 · ClinicalTrials.gov registry record · Phase 3

12-Week Study of Plecanatide for CIC (The National CIC3 Study)

A Phase 3 study of Chronic Idiopathic Constipation, sponsored by Bausch Health Americas.

Completed
Registry status
Phase 3
Development phase
1,410
Enrollment target
20
Study locations

NCT02122471 is a Phase 3 study of Chronic Idiopathic Constipation that has completed, run by Bausch Health Americas. The registered enrollment target is 1,410 participants, above the 539-participant average among 6 other Chronic Idiopathic Constipation trials with a reported enrollment target (162% higher). The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02122471, a Phase 3 study of Chronic Idiopathic Constipation, has completed, sponsored by Bausch Health Americas.

COMPLETED
Registry status
Phase 3
Development phase
1,410 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.

Conditions Studied

Chronic Idiopathic Constipation

Interventions

  • DRUG Placebo
  • DRUG Plecanatide

Study Locations (20)

California

  • Synergy Research Site - Anaheim
  • Synergy Research Site - Artesia
  • Synergy Research Site - Carmichael
  • Synergy Research Site - Corona
  • Synergy Research Site - Encino
  • Synergy Research Site - Garden Grove
  • Synergy Research Site - Garden Grove
  • Synergy Research Site - Glendale
  • Synergy Research Site - La Mirada
  • Synergy Research Site - Laguna Hills
  • Synergy Research Site - Los Angeles

Arizona

  • Synergy Research Site - Chandler
  • Synergy Research Site - Goodyear
  • Synergy Research Site - Tucson
  • Synergy Research Site - Tucson
  • Synergy Research Site - Tucson
  • Synergy Research Site - Tucson
  • Synergy Research Site - Tucson

Alabama

  • Synergy Research Site - Anniston
  • Synergy Research Site - Huntsville

Trial Details

FieldValue
Enrollment Target 1,410 participants
Start Date 2014-04
Est. Completion 2015-07
Phase Phase 3

Sponsor

Bausch Health Americas

168 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02122471

The ClinicalTrials.gov registry entry for NCT02122471 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,410 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 539-participant average among 6 other Chronic Idiopathic Constipation trials with a reported enrollment target (162% higher). The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Idiopathic Constipation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02122471 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Arizona, Alabama.

Frequently Asked Questions

What is clinical trial NCT02122471 about?

NCT02122471 is a clinical study titled "12-Week Study of Plecanatide for CIC (The National CIC3 Study)". The purpose of this study is to confirm that the investigational medication, plecanatide, is safe and effective in treating chronic idiopathic constipation.

What is the current status of trial NCT02122471?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,410 participants. The study started on 2014-04. Estimated completion is 2015-07.

What conditions does trial NCT02122471 study?

This clinical trial studies the following conditions: Chronic Idiopathic Constipation.

What interventions are being tested in trial NCT02122471?

The interventions under investigation include: Placebo (DRUG), Plecanatide (DRUG).

Who is sponsoring clinical trial NCT02122471?

This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02122471 being conducted?

This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Idiopathic Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Idiopathic Constipation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.